Aug 2026· Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease· pp.
e050310
· 0 citations· 10 references
Medicine
TL;DR
TEER was associated with a greater reduction in right atrial pressure and more favorable RV remodeling at 30 days, as opposed to TTVR, which achieved more complete and sustained elimination of tricuspid regurgitation with higher forward stroke volume.
Abstract
Background
Transcatheter edge-to-edge repair (TEER) and replacement (TTVR) have emerged as new modalities to treat patients with symptomatic significant tricuspid regurgitation. This study aimed to compare invasive hemodynamic and right ventricular (RV) changes and symptom improvement over 1 year.
Methods
Patients who underwent TEER/TTVR at Mayo Clinic (Rochester, MN, 2017-2024) were included. Hemodynamic profiles were described before and immediately after intervention, in addition to RV enlargement/dysfunction ≥moderate at 30 days and change in symptoms over time.
Results
Of 100 patients included (50 per group, median age 81 versus 80 years and female 62% versus 42%, in TTVR and TEER, respectively), all had ≥ moderate-severe symptomatic tricuspid regurgitation. Post intervention, mean right atrial pressure decreased in TEER (16 to 14 mm Hg, P<0.001), V wave decreased in both groups (to 16 mm Hg, P<0.001). RV enlargement was less prevalent in both cohorts at 30 days (60%-40% in TEER, P=0.01, and 72 to 58% in TTVR, P=0.07), yet prevalence of RV dysfunction decreased only in TEER (26 to 15%, P=0.17) as opposed to TTVR (31 to 44%, P=0.13). TTVR resulted in a higher stroke volume index and more complete tricuspid regurgitation elimination at 30 days. Both groups resulted in similar improvements in New York Heart Association class, with overall similar survival.
Conclusions
TEER was associated with a greater reduction in right atrial pressure and more favorable RV remodeling at 30 days, as opposed to TTVR, which achieved more complete and sustained elimination of tricuspid regurgitation with higher forward stroke volume.
TTVR with both, the Cardiovalve and EVOQUE prothesis is an effective treatment option, leading to profound TR reduction and meaningful clinical improvement at 30-day follow-up.
Florian Genske, Judith Heine, C. Marquetand et al.· Frontiers in Cardiovascular...· 0 citations
OBJECTIVES
In high-risk patients, transcatheter mitral valve replacement (TMVR) is an alternative to surgery and transcatheter edge-to-edge repair (TEER). This study aims to evaluate the mid-term results of TMVR with the Tendyne System in a real-world population at a single center.
METHODS
Between November 2018 and D...
L. Besola, Cristina Di Franco, F. Giorgi et al.· Interdisciplinary cardiovasc...· 0 citations
Abstract Background Severe tricuspid regurgitation (TR) induces right ventricular (RV) volume overload and disrupts biventricular mechanics. Tricuspid transcatheter edge-to-edge repair (T-TEER) and transcatheter tricuspid valve replacement (TTVR) are effective strategies to reduce or eliminate TR, yet their immediate p...
G. Mondellini, A. V. D. van den Enden, M. V. D. van den Dorpel et al.· European Heart Journal: Case...· 0 citations
BACKGROUND
Dedicated transcatheter aortic valve replacement (TAVR) devices for the treatment of pure aortic regurgitation (AR) have emerged as an alternative to surgery for patients at high or prohibitive operative risk. However, the immediate hemodynamic effects of TAVR in this setting remain poorly characterized.
C...
G. Mondellini, Lucas Uchoa de Assis, R. Nuis et al.· JACC Case Reports· 0 citations
Findings indicate that both valve and ventricular tissues retain a persistent remodeled phenotype post-unloading, and this persistent altered phenotype may represent a biological contribution of the TV leaflets to recurrent TR with implications for long-term outcomes following treatment of FTR.
Boguslaw Gaweda, Austin Goodyke, Jeremy W. Prokop et al.· bioRxiv· 0 citations
ABSTRACT Introduction Severe tricuspid regurgitation (TR) is common, undertreated, and associated with significant morbidity and mortality. Transcatheter tricuspid valve replacement (TTVR) has emerged as a promising option for patients unsuitable for surgical repair or transcatheter edge-to-edge repair. Areas covered T...
G. Calamita, P. Leone, Ossama Elsaid et al.· Expert Review of Medical Dev...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.